McKesson (MCK) is scheduled to announce Q2 earnings results on Wednesday, November 5th, after market close. The consensus EPS ...

Analysts anticipate McKesson to report an earnings per share (EPS) of $9.00. McKesson bulls will hope to hear the company ...

• Coherent (COHR) - EPS: $1.04, Revenue: $1.54B • CONMED Corp (CNMD) - EPS: $1.05, Revenue: $334.71M • Consensus Cloud Solutions (CCSI) - EPS: $1.33, Revenue: $87.6M • Corrections Corp (CXW) - EPS: $0 ...

Baltimore City faces a possible reversal of a $152.3 million opioid judgment against McKesson and Cencora after McKesson ...

In October 2025, Citius Oncology announced a distribution services agreement with McKesson, making McKesson an authorized distributor of record for LYMPHIR, a newly FDA-approved immunotherapy for ...

Beyond analysts' top-and-bottom-line estimates for McKesson (MCK), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ...

McKesson (MCK) declares $0.82/share quarterly dividend, in line with previous. Forward yield 0.41% Payable Jan. 2; for ...

Deal Rationale McKesson’s strategic focus on disciplined portfolio management involves continuous evaluation of its business segments to ensure alignment with its growth priorities and optimize ...

In October, we joined forces with the Washington Post and reported a disturbing story of Washington at its worst - about an act of Congress that crippled the DEA's ability to fight the worst drug ...